Can a normal nuchal translucency (NT) measurement coexist with an abnormal Non-Invasive Prenatal Test (NIPT) result?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can You Have Normal Nuchal Translucency but Abnormal NIPT?

Yes, you can absolutely have a normal nuchal translucency (NT) measurement with an abnormal NIPT result—these are independent screening tests that assess different aspects of fetal risk and do not always correlate. 1, 2

Why This Discordance Occurs

Different Screening Mechanisms

  • NT measures a physical finding (the fluid-filled space at the back of the fetal neck) that correlates with aneuploidy risk but detects only approximately 70% of trisomy 21 cases when used alone 1, 3
  • NIPT analyzes cell-free fetal DNA in maternal blood and has a higher detection rate for trisomy 21,18, and 13 specifically, but screens a narrower range of conditions 2
  • These tests are measuring fundamentally different markers, so normal results on one test do not guarantee normal results on the other 1

Clinical Reality of Discordant Results

  • A fetus can have a chromosomal abnormality (detected by NIPT) without having increased nuchal fluid accumulation 1, 3
  • Conversely, increased NT can occur in chromosomally normal fetuses due to cardiac defects, genetic syndromes like Noonan syndrome or 22q11.2 deletion, or other structural anomalies that NIPT cannot detect 2, 4

Management When NIPT is Abnormal Despite Normal NT

Immediate Next Steps

  • Offer genetic counseling and diagnostic testing with chorionic villus sampling (CVS) or amniocentesis to confirm the NIPT result, as NIPT is a screening test that requires confirmation before making definitive clinical decisions 2, 4
  • Do not rely on the normal NT measurement to provide false reassurance—proceed with diagnostic confirmation of the abnormal NIPT 4, 5

Important Limitations to Recognize

  • NIPT only screens for common trisomies (21,18,13) and sex chromosome aneuploidies, missing other chromosomal abnormalities, subchromosomal deletions/duplications, and genetic syndromes 2, 4
  • If diagnostic testing (karyotype and chromosomal microarray analysis) is performed, it may reveal additional findings beyond what NIPT screens for—studies show that invasive testing detects clinically significant abnormalities in 3.1% of cases with normal NIPT results when ultrasound anomalies are present 4

Critical Pitfalls to Avoid

Don't Skip the Anatomy Scan

  • Even with normal NIPT and normal NT, a detailed second trimester anatomic survey at 18-22 weeks remains mandatory 2, 3
  • NT screening should never replace the standard second trimester fetal survey, as sensitivity for detecting congenital anomalies at 11-14 weeks is only 50% compared to 75% at 18-22 weeks 3

Don't Assume NIPT Covers Everything

  • NIPT misses structural heart defects, skeletal dysplasias, other genetic syndromes, and chromosomal abnormalities beyond the common trisomies 2, 4
  • In one study of pregnancies with ultrasound anomalies, NIPT would have missed more than 15% of chromosomal abnormalities that were detected by invasive testing 5

Understand the Residual Risk

  • When NT is in the 3.0-3.4 mm range (borderline increased), even with normal NIPT for common trisomies, the residual risk for missing a chromosomal aberration is approximately 1 in 21 (4.8%) 6
  • This residual risk can be lowered to approximately 1 in 464 if genome-wide NIPT with 10-Mb resolution is used, but standard NIPT does not provide this level of coverage 6

The Bottom Line on Test Independence

Normal NT does not predict normal NIPT, and vice versa—they provide complementary but distinct information about fetal risk. 1, 2 When results are discordant, always proceed with diagnostic confirmation and comprehensive fetal evaluation including detailed anatomy scan and fetal echocardiography. 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Early Maternal Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Nuchal Translucency Scan Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical utility of non-invasive prenatal testing in pregnancies with ultrasound anomalies.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.